About this trial
Migraine is a significant health problem due to its high prevalence and substantial contribution to disability. Individuals with migraine have been reported to exhibit myofascial trigger points, increased pain sensitivity, and altered muscle activation patterns, particularly in the trapezius muscles. As the upper and middle trapezius muscles play critical roles in scapular stability and movement, alterations in these muscles may affect scapular orientation and upper extremity function. However, studies investigating the relationship between trapezius muscle activation, scapular orientation, and upper extremity performance in individuals with migraine are limited. Therefore, this study aimed to compare trapezius muscle activation, scapular orientation, and upper extremity performance between individuals with and without migraine. We hypothesized that individuals with migraine would exhibit altered upper and middle trapezius muscle activation, impaired scapular orientation, and reduced upper extremity performance compared with healthy controls.
Eligibility criteria
Qualifiers
Aged 18-55 years
Diagnosed with migraine by a neurologist according to the ICHD-3 criteria
Experiencing at least 3 migraine attacks per month
Willing to participate and provide written informed consent
Disqualifiers
Presence of other types of headache disorders
History of trauma, fracture, or surgery involving the cranio-cervical region, scapular region, or upper extremity
Presence of neurological or inflammatory rheumatic diseases
Presence of psychiatric disorders
Trial design
Treatments tested in this trial
- Not listed